Prostate Cancer Flashcards

(34 cards)

1
Q

Normal size of prostate gland

A

walnut

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

make fluid contained in the seminal fluid which nourishes sperm

A

prostate gland

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Zone that surrounds proximal urethra

A

transition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Zone that surround ejaculatory ducts

A

central

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Zone that surround distal urethra and where most BPH occurs

A

peripheral

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Prognosis of prostate cancer

A

5 yr survival nearly 100%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Racial group more often affected by prostate cancer

A

African Americans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Presenting symptoms include increased urinary frequency, painful micturition, decreased stream, hematuria, painful ejaculation

A

prostate cancer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

At what level is the PSA when prostate cancer develops

A

usually above 4

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Factors that increase PSA

A

BPH, age, prostatitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Relates PSA level to size of prostate

A

PSA density

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Change in PSA over time

A

PSA velocity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

low number suggests cancer, since more free PSA from normal prostate is degradated

A

Free PSA/Total PSA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the levels of the Gleason scores

A

2-4 Best (cells still look normal). 5-7 Intermediate risk. 8-10 Worse (cells have few features of a normal cell and are likely to be aggressive)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Therapy for T1a patient

A

if greater than 60 follow with no therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Therapy for a T1b, T1c, T2 patient

A

radical prostatectomy or high dose radiation

17
Q

Therapy for a T3 (stage 3) patient

18
Q

How long is the average doubling time of a prostate tumor?

A

slow, 2-4 yrs

19
Q

Nerve sparing procedure. allows neurovascular bundles on either side of prostate that control erectile fxn. Remaining Urethra is sewn to bladder neck over a catheter

A

Radical Retropubic Prostatectomy (RRP)

20
Q

Whole prostate can be examined histologically.

Surgeon has access to lymph nodes to test if prostate cancer cells have left the tumor. Surgical margin can be examined

A

Radical Retropubic Prostatectomy (RRP)

21
Q

Cannot access regional lymph nodes. Slight increase in risk of rectal injury and associated complications

A

Perineal Prostatectomy

22
Q

Radioactive seed implants into prostate. ED less common side effect

A

brachytherapy

23
Q

Maximize damage to the prostate and minimize damage to surrounding tissues. ED less common side effect

A

External Beam Radiation

24
Q

initial therapy for locally advanced or metastatic disease

A

hormonal therapy

25
What hormones do prostate cells and prostate cancer cells depend on for survival and growth?
androgens
26
may be performed prior to prostatectomy or radiation in order to shrink the tumor. standard method of treating advanced and metastatic prostate cancer
androgen ablation therapy (ie hormone therapy)
27
surgical removal of the testicles.
orchiectomy (castration)
28
Name the LHRH analogs
Goserelin (Zolodex) | Leuprolide (Lupron)
29
Name the antiandrogens
Flutamide, bicalutamide, nilutamide
30
Primary value when starting LHRH to limit the flare reaction
antiandrogens
31
Consequences of this treatment include: impotence, decreased libido, hot flashes, weight gain, fatigue, loss of bone/muscle mass
androgen removal
32
Treatment of hormone refractory metastatic disease
Docetaxel (every 3 wks), prednisone, and bisphosphonates
33
Complications of anti-adrogen therapy
diarrhea and hepatic dysfxn
34
5-alpha reductase inhibitor, blocks intracellular conversion of testosterone to dihydrotestosterone
Finasteride